At this time, posts about Hyundai Pharm are rapidly increasing on portals and securities communities. Today, foreigners have sold a net 175,000 shares of Hyundai Pharm, while institutions have bought a net 2,000 shares, according to provisional data. Hyundai Pharm is known as a manufacturer of health beverages such as Miero Fiber and pharmaceuticals.


As of 12:30 PM on the 29th, Hyundai Pharm's stock price is 7,240 KRW, up 3.43% from the previous day, with a trading volume of 6,362,709 shares, which is 18.61% of the 5-day average trading volume. On December 23rd, Hyundai Pharm was an issue in the market with the headline "Following yesterday's upper limit price, a surge continues."


In addition to Hyundai Pharm, posts by investors are also rapidly increasing regarding Daehan Science (131220), Samgi (122350), and Industrial Bank of Korea (024110).



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing